Literature DB >> 27039179

The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases.

Peter Sondermann1.   

Abstract

FcγRs are a crucial component of the antibody response as they mediate the cellular effector functions in response to IgG-containing immune complexes (ICs). Therefore, they also play a central role in the pathogenesis of autoimmune diseases which offers an attractive option to specifically target this class of molecules and their interaction with IgG for treatment of immune disorders. In detail, two strategies are discussed in this article. SM101, a soluble FcγR that is already in clinical development competes with the interaction of IgG with membrane FcγRs. Oppositely, SM201 recruits the inhibitory FcγRIIB for a broad down-modulation of the immune system. The presented approaches for the treatment of autoimmune diseases have the potential be more efficacious with fewer side effects than the currently used therapeutic options.

Entities:  

Keywords:  Fc-gamma receptor; FcγR; FcγRIIB; IgG; SM101; SM201; soluble FcγR

Mesh：

Substances：

Year:  2016        PMID： 27039179     DOI： 10.1007/s10875-016-0272-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


  34 in total

1.  Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines.

Authors:  L Pricop; P Redecha; J L Teillaud; J Frey; W H Fridman; C Sautès-Fridman; J E Salmon
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

Review 2.  X-ray crystallographic studies of IgG-Fc gamma receptor interactions.

Authors:  P Sondermann; V Oosthuizen
Journal:  Biochem Soc Trans       Date:  2002-08       Impact factor: 5.407

3.  Immunoglobulin-binding factor present on and produced by thymus-processed lymphocytes (T cells).

Authors:  W H Fridman; P Golstein
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

Review 4.  Ligands and biological activities of soluble Fc gamma receptors.

Authors:  J Galon; C Bouchard; W H Fridman; C Sautès
Journal:  Immunol Lett       Date:  1995-01       Impact factor: 3.685

5.  Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.

Authors:  Seung Y Chu; Karen Yeter; Roshan Kotha; Erik Pong; Yvonne Miranda; Sheryl Phung; Hsing Chen; Sung-Hyung Lee; Irene Leung; Christine Bonzon; John R Desjarlais; William Stohl; David E Szymkowski
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

6.  SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis.

Authors:  R N Pearse; T Kawabe; S Bolland; R Guinamard; T Kurosaki; J V Ravetch
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

7.  Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.

Authors:  Sofia E Magnusson; Maria Andrén; Kajsa E Nilsson; Peter Sondermann; Uwe Jacob; Sandra Kleinau
Journal:  Clin Immunol       Date:  2008-03-17       Impact factor: 3.969

8.  Soluble CD16 in the treatment of murine lupus nephritis.

Authors:  H Watanabe; D Sherris; G S Gilkeson
Journal:  Clin Immunol Immunopathol       Date:  1998-07

9.  Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance between shedding and secretion?

Authors:  C de la Salle; M E Esposito-Farese; T Bieber; J Moncuit; M Morales; A Wollenberg; H de la Salle; W H Fridman; J P Cazenave; J L Teillaud
Journal:  J Invest Dermatol       Date:  1992-11       Impact factor: 8.551

Review 10.  IgG subclasses and allotypes: from structure to effector functions.

Authors:  Gestur Vidarsson; Gillian Dekkers; Theo Rispens
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561
View more
  9 in total

1.  Ins and Outs of Antibodies.

Authors:  Sudhir Gupta
Journal:  J Clin Immunol       Date:  2016-05-12       Impact factor: 8.317

Review 2.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

Review 3.  Autoimmunity and primary immunodeficiency: two sides of the same coin?

Authors:  Reinhold E Schmidt; Bodo Grimbacher; Torsten Witte
Journal:  Nat Rev Rheumatol       Date:  2017-12-19       Impact factor: 20.543

Review 4.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

Review 5.  Fcγ Receptor Heterogeneity in Leukocyte Functional Responses.

Authors:  Carlos Rosales
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

6.  Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells.

Authors:  Ben F Brian; Adrienne S Jolicoeur; Candace R Guerrero; Myra G Nunez; Zoi E Sychev; Siv A Hegre; Pål Sætrom; Nagy Habib; Justin M Drake; Kathryn L Schwertfeger; Tanya S Freedman
Journal:  Elife       Date:  2019-07-08       Impact factor: 8.140

7.  Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.

Authors:  Linlin Sheng; Xiuqin Cao; Shuhong Chi; Jing Wu; Huihui Xing; Huiyu Liu; Zhiwei Yang
Journal:  Int J Mol Med       Date:  2020-08-07       Impact factor: 4.101

Review 8.  Novel Therapies to Address Unmet Needs in ITP.

Authors:  María Eva Mingot-Castellano; José María Bastida; Gonzalo Caballero-Navarro; Laura Entrena Ureña; Tomás José González-López; José Ramón González-Porras; Nora Butta; Mariana Canaro; Reyes Jiménez-Bárcenas; María Del Carmen Gómez Del Castillo Solano; Blanca Sánchez-González; Cristina Pascual-Izquierdo
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-23

9.  Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses.

Authors:  Bo Chen; Katherine A Vousden; Brian Naiman; Sean Turman; Hong Sun; Shu Wang; Lisa M K Vinall; Benjamin P Kemp; Srinath Kasturiangan; D Gareth Rees; Ethan Grant; Mary Jane Hinrichs; Steven Eck; Antonio DiGiandomenico; M Jack Borrok; Neang Ly; Ximing Xiong; Carlos Gonzalez; Christopher Morehouse; Yue Wang; Yebin Zhou; Jennifer Cann; Weiguang Zhao; Holly Koelkebeck; Koshu Okubo; Tanya N Mayadas; David Howe; Janet Griffiths; Roland Kolbeck; Ronald Herbst; Gary P Sims
Journal:  Ann Rheum Dis       Date:  2018-11-20       Impact factor: 19.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.